Review



multi omics data  (Foundation Medicine Inc)


Bioz Verified Symbol Foundation Medicine Inc is a verified supplier
Bioz Manufacturer Symbol Foundation Medicine Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Foundation Medicine Inc multi omics data
    Multi Omics Data, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 2410 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/FoundationOne+CDx/pm42034603-270-30-37
    Average 99 stars, based on 2410 article reviews
    multi omics data - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Oligomer Restriction:

    Article Title: Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
    Article Snippet: uacy dropped to 79.7%, revealing substantial heterogeneity across studies and clinical settings. 7 Other studies have reported even lower success rates for CGP, with one study demonstrating an overall FoundationOne CDx success rate of only 67.9% from EUS‐guided specimens. 3 The broad heterogeneity of molecular sufficiency of PDAC specimens seen in the literature can be largely ascribed to the varia

    Immunohistochemistry:

    Article Title: Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
    Article Snippet: uacy dropped to 79.7%, revealing substantial heterogeneity across studies and clinical settings. 7 Other studies have reported even lower success rates for CGP, with one study demonstrating an overall FoundationOne CDx success rate of only 67.9% from EUS‐guided specimens. 3 The broad heterogeneity of molecular sufficiency of PDAC specimens seen in the literature can be largely ascribed to the varia

    FISH:

    Article Title: Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
    Article Snippet: uacy dropped to 79.7%, revealing substantial heterogeneity across studies and clinical settings. 7 Other studies have reported even lower success rates for CGP, with one study demonstrating an overall FoundationOne CDx success rate of only 67.9% from EUS‐guided specimens. 3 The broad heterogeneity of molecular sufficiency of PDAC specimens seen in the literature can be largely ascribed to the varia

    In Situ:

    Article Title: Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
    Article Snippet: uacy dropped to 79.7%, revealing substantial heterogeneity across studies and clinical settings. 7 Other studies have reported even lower success rates for CGP, with one study demonstrating an overall FoundationOne CDx success rate of only 67.9% from EUS‐guided specimens. 3 The broad heterogeneity of molecular sufficiency of PDAC specimens seen in the literature can be largely ascribed to the varia

    Fluorescence:

    Article Title: Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
    Article Snippet: uacy dropped to 79.7%, revealing substantial heterogeneity across studies and clinical settings. 7 Other studies have reported even lower success rates for CGP, with one study demonstrating an overall FoundationOne CDx success rate of only 67.9% from EUS‐guided specimens. 3 The broad heterogeneity of molecular sufficiency of PDAC specimens seen in the literature can be largely ascribed to the varia

    Diagnostic Assay:

    Article Title: Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
    Article Snippet: uacy dropped to 79.7%, revealing substantial heterogeneity across studies and clinical settings. 7 Other studies have reported even lower success rates for CGP, with one study demonstrating an overall FoundationOne CDx success rate of only 67.9% from EUS‐guided specimens. 3 The broad heterogeneity of molecular sufficiency of PDAC specimens seen in the literature can be largely ascribed to the varia

    Mutagenesis:

    Article Title: Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
    Article Snippet: uacy dropped to 79.7%, revealing substantial heterogeneity across studies and clinical settings. 7 Other studies have reported even lower success rates for CGP, with one study demonstrating an overall FoundationOne CDx success rate of only 67.9% from EUS‐guided specimens. 3 The broad heterogeneity of molecular sufficiency of PDAC specimens seen in the literature can be largely ascribed to the varia

    Next-Generation Sequencing:

    Article Title: Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
    Article Snippet: uacy dropped to 79.7%, revealing substantial heterogeneity across studies and clinical settings. 7 Other studies have reported even lower success rates for CGP, with one study demonstrating an overall FoundationOne CDx success rate of only 67.9% from EUS‐guided specimens. 3 The broad heterogeneity of molecular sufficiency of PDAC specimens seen in the literature can be largely ascribed to the varia

    Sequencing:

    Article Title: Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
    Article Snippet: uacy dropped to 79.7%, revealing substantial heterogeneity across studies and clinical settings. 7 Other studies have reported even lower success rates for CGP, with one study demonstrating an overall FoundationOne CDx success rate of only 67.9% from EUS‐guided specimens. 3 The broad heterogeneity of molecular sufficiency of PDAC specimens seen in the literature can be largely ascribed to the varia



    Similar Products

    86
    Omics Data Automation multi layer omics data
    Multi Layer Omics Data, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/data+layer+multi+omics/pm42312475-200-30-31
    Average 86 stars, based on 1 article reviews
    multi layer omics data - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Omics Data Automation multi omics data analysis
    Multi Omics Data Analysis, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/analysis+data+multi+omics/pm42316250-283-13-13
    Average 86 stars, based on 1 article reviews
    multi omics data analysis - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Omics Data Automation cancer subtype classification leveraging multi omics data
    Cancer Subtype Classification Leveraging Multi Omics Data, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/cancer+data+multi+omics+pan/pm42300227-445-12-16
    Average 86 stars, based on 1 article reviews
    cancer subtype classification leveraging multi omics data - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Omics Data Automation deep learning based multi omics data integration approach
    Deep Learning Based Multi Omics Data Integration Approach, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/approach+based+data+deep+integration+learning+multi+omics/pm42168900-290-22-24
    Average 86 stars, based on 1 article reviews
    deep learning based multi omics data integration approach - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Omics Data Automation clinical multi omics data analysis transcriptomic
    Clinical Multi Omics Data Analysis Transcriptomic, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/analysis+data+multi+omics/pm42151394-270-0-1
    Average 86 stars, based on 1 article reviews
    clinical multi omics data analysis transcriptomic - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Omics Data Automation multi omics data • flexible integration
    Multi Omics Data • Flexible Integration, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/data+integration+multi+omics/pmc13174227-39-8-26
    Average 86 stars, based on 1 article reviews
    multi omics data • flexible integration - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Omics Data Automation multi omics data integration approaches
    Multi Omics Data Integration Approaches, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/approach+based+data+deep+integration+learning+multi+omics/pm42043678-521-4-26
    Average 86 stars, based on 1 article reviews
    multi omics data integration approaches - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    99
    Foundation Medicine Inc multi omics data
    Multi Omics Data, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/FoundationOne+CDx/pm42034603-270-30-37
    Average 99 stars, based on 1 article reviews
    multi omics data - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    86
    Omics Data Automation multi omics data imputation
    Multi Omics Data Imputation, supplied by Omics Data Automation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multi+omics+data/data+imputation+multi+omics/10__1002_slash_aidi__202500249-346-12-12
    Average 86 stars, based on 1 article reviews
    multi omics data imputation - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results